ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan's drug sector to unite for emerging-market push

Tokyo will help establish financial, legal footing for cross-industry group

Japanese drugmakers and distributors, among others, will team up to gain a foothold in Vietnam and other developing economies.

TOKYO -- Around 25 Japanese companies including Eisai and Takeda Pharmaceutical plan to jointly develop and distribute medicines in emerging economies, leveraging a government partnership to take on Western giants.

The group will aim to develop markets for medicines in such regions as Asia and Africa. Members will form a corporation within the year under government leadership and kick off operations in Vietnam and Thailand in fiscal 2019.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more